Abstract
Objective: Clinicians have begun using several mood stabilizers for treating agitation in older patients, but limited information is available relative to side effects and costs in clinical practice. To address this issue, medication-related adverse events and their costs were reviewed in a group of older nursing home patients receiving divalproex or lithium. Subjects and Methods: 72 subjects were identified as having received one of the mood stabilizers for at least several months during some point between 1994 and 1997, were age 55 years or older, and who resided in the skilled nursing facility at the Veterans Administration Medical Center in Long Beach, California.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
